Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-03

FDA Approved: DETECTNET — Original Application (CURIUM US LLC)

View source ↗

Summary

FDA approved DETECTNET (Copper-64 DOTATATE) from Curium US LLC for PET imaging of neuroendocrine tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DETECTNET (Copper-64 DOTATATE)

Snippet

ORIG AP for DETECTNET (COPPER CU 64 DOTATATE)